Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine <i>via</i> cuproptosis-Reference-Cited by-同舟云学术

Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis

Published:2022 Issue:33 Volume:10 Page:6296-6306
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Lu Yao¹^ORCID,Pan Qingqing²^ORCID,Gao Wenxia³^ORCID,Pu Yuji¹^ORCID,He Bin¹^ORCID

Affiliation:

1. National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China

2. School of Preclinical Medicine, Chengdu University, Chengdu, 610106, China

3. College of Chemistry & Materials Engineering, Wenzhou University, Wenzhou, 325027, China

Abstract

A copper nanomedicine shows the glutathione-resistant anticancer effect and reverses cisplatin chemotherapy resistance in non-small-cell lung cancer by cuproptosis.

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D2TB01150F

Reference47 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. Platinum Resistance in Ovarian Cancer: Role of DNA Repair

3. The rediscovery of platinum-based cancer therapy

4. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

5. Cisplatin resistance and opportunities for precision medicine

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing nanomaterials for copper-induced cell death;Biomaterials;2025-02

2. Synthesis and anti-cancer investigations of copper(II) complexes based on adenine;Journal of Molecular Structure;2024-11

3. Innovative Strategies in Cancer Treatment: Harnessing Cuproptosis and Nanotechnology for Targeted Therapy;Drug Discovery Today;2024-10

4. Integrating multi-omics and machine learning survival frameworks to build a prognostic model based on immune function and cell death patterns in a lung adenocarcinoma cohort;Frontiers in Immunology;2024-09-13

5. Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy;International Journal of Molecular Sciences;2024-09-07